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Virion assemblysystem was developed to produce and isolate bovine viral diarrhea virus (BVDV)
pseudo-particles with complementing reporter replicons and their packaging proteins expressed in trans
with recombinant vaccinia virus. The encapsidation of replicon rNS3-5B was dependent not only on the in
trans expression of structural proteins C, Erns, E1 and E2, but also the nonstructural proteins, p7 and
contiguous precursor NS2-3-4A. Nonstructural p7, NS4B, NS5A or NS5B could be expressed in cis and in trans
with precursor NS2-3-4A without signiﬁcantly affecting virion assembly efﬁciency. NS2-3-4A was identiﬁed
as an in trans functional precursor in virion assembly. BVDV genomes with mutant NS5B, which did not
undergo active replication, were packaged 5-fold less efﬁciently than the intact genomes demonstrating the
importance of replication in virion packaging. These results suggest that genome replication and assembly
are closely associated, consistent with a model in which these two steps are coupled for maximum efﬁciency.
© 2009 Elsevier Inc. All rights reserved.IntroductionBovine viral diarrhea virus (BVDV) is an economically important
pathogen of domestic livestock and wild ruminants. The virus is a
member of the genus Pestivirus, which together with the Flavivirus and
Hepacivirus genera constitute the family Flaviviridae (Van Regenmortel,
1999). The genome of BVDV is approximately 12.3 kb in length and
consists of a single long open reading frame (ORF) ﬂanked by 5′ and 3′
nontranslated regions (NTRs) (Collett et al.,1988). Translationof theORF
ismediated by an internal ribosome entry site (IRES) (Poole et al.,1995).
The ORF is translated into a single large polyprotein which is co- and
post-translationally processed into at least 11 mature structural and
nonstructural (NS) viral proteins as follows: Npro-capsid (C)-Erns-E1-E2-
p7-NS2-3-NS4A-NS4B-NS5A-NS5B (Collett et al., 1988; Elbers et al.,at Inﬂuenza Division, NCIRD,
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ll rights reserved.1996; Tautz et al., 1997). Npro is an autoprotease that cleaves at its own
carboxyl-terminus to release the C protein (Rumenapf et al., 1998). The
cleavages of C, Erns, E1, E2 and p7 are catalyzed by host cellular signal
peptidases (Rumenapf et al., 1993, 1998). The N-terminal, one-third of
NS3 encodes a serine protease that functions in concert with cofactor
NS4A tomediate processingof all downstreamNSproteins (Collett et al.,
1988; Failla et al., 1994). BVDV isolates are divided into noncytopathic
(ncp) and cytopathic (cp) biotypes that are distinguished by their effect
on cultured cells (Gillespie et al., 1960). Expression of NS3 as a separate
protein is a hallmark of cp-BVDV (Donis and Dubovi, 1987). NS3 is co-
linear to the C-terminal portion of NS2-3 and its expression by cp-BVDV
is the result of complex genetic changes (Meyers et al., 1996). However,
an almost complete cleavage of NS2-3 in ncp-BVDV during the early
hours of infection has been reported recently, indicating that temporal
modulation of NS2-3 processing is crucial for replication and patho-
genicity (Lackner et al., 2004).
Genetic analyses have shown that genome replication requires the
ﬁveNSproteins,NS3,NS4A,NS4B,NS5AandNS5B,ofwhichonlyNS5A is
complementable in trans (Grassmann et al., 2001; Moser et al., 1999;
Tautz et al., 1999). The known relevant catalytic functions in this
complex are the nucleotidyl transferase of NS5B (Lai et al.,1999; Steffens
et al., 1999), as well as the ATPase and RNA helicase of NS3 (Grassmann
et al., 1999). The roles of NS4A, NS4B and NS5A in RNA replication are
unknown (Qu et al., 2001). Pestivirus virions are enveloped particles
between 40–60 nm in diameter. They consist of viral genomic RNA, the C
protein, the envelope glycoproteins Erns, E1, and E2, as well as the lipid
332 D. Liang et al. / Virology 387 (2009) 331–340membraneenvelope. Electronmicroscopyof infected cells has suggested
that particles bud into the lumen of cytoplasmic vesicular structures
(Ohmann, 1990). The mechanism by which genomic RNA is incorpo-
rated into virions during budding remains unknown. The spatial
relationships between the sites of RNA replication and virion assembly
are not known and RNA packaging signals have not been identiﬁed in
any of the Flaviviridae members. There is a growing body of evidence
indicating that Pestivirus NS proteins participate in the assembly of
infectious virions (Agapov et al., 2004; Ansari et al., 2004). However, it is
not known how theNS proteins contribute to the assembly process. One
possibility is that certain NS proteins participate in coupling the genome
replication process to that of virion assembly. The results described in
this study demonstrate a signiﬁcant involvement of NS proteins in
genome packaging and also suggest that genome packaging is more
efﬁcient when coupled to an active replicase complex.
Results
Development of an efﬁcient BVDV virion packaging assay system
We recently reported the development and use of a bicistronic
replicon derived from the cp-BVDV strain NADL that expresses ﬁreﬂyFig. 1. Replication and packaging of subgenomic BVDV replicons by helper virus. (A) Schem
F-luc=ﬁreﬂy luciferase, Ubi=ubiquitin, Neo=neomycin phosphotransferase and EMCV=in
measured at the indicated hours post-electroporation (hpe) with RNA transcripts of rNS3-5B (ﬁ
were normalized for electroporation efﬁciency by measuring the Renilla luciferase from a mono
the repeated experiments. (C) Northern blotting analysis to determine replication efﬁciency
electroporationwith RNA transcripts. RNA derived from rNS3-5Bgdd served as a control (lane 1
an image of the ethidium bromide stained agarose gel of total cellular RNA that was blotted and
supernatant collected from cells persistently infected by ncp-BVDV-2 helper virus for 36 h befo
post-RNA electroporation or infection with packaged/pseudotyped replicon RNAs. Packageable
and used for the transduction of indicator cells. Transduced replicons refer to replicons recoveluciferase to facilitate detection of its biological activity within
electroporated cells (Ansari et al., 2004; Horscroft et al., 2005; Vassilev
and Donis, 2000). This replicon, termed rNS3-5B, expresses the
minimal complement of NS proteins required for genome replication
(Ansari et al., 2004; Behrens et al., 1998). To study the role of NS
proteins in BVDV genome packaging into virions, we constructed an
additional reporter replicon, termed rp7-NS5B (Fig. 1A). The upstream
cistron of this replicon expresses ﬁreﬂy luciferase and neomycin
phosphotransferase, whereas the second cistron expresses the poly-
protein encoding the complete set of NS proteins starting from p7 to
NS5B, hence rp7-NS5B is approximately 1.5 kb longer than rNS3-5B.
The expression of the second cistron is mediated by the encephalo-
myocarditis virus (ECMV) IRES. The RNA transcripts derived from both
replicons resulted in the expression of increased levels of ﬁreﬂy
luciferase following RNA electroporation into bovine cells. Luciferase
activity was detected as early as 24 h post-electroporation and was
maximal at 48 h (Fig. 1B). Both replicons, rNS3-5B and rp7-NS5B,
expressed equivalent levels of luciferase. In contrast, cells electro-
poratedwith rNS3-5Bgdd, showed only background levels of luciferase
activity, indicating that the signiﬁcant levels of luciferase activity
observed after rNS3-5B or rp7-NS5B were dependent on the
polymerase activity of NS5B to mediate RNA ampliﬁcation (Fig. 1B).atic diagram of bicistronic reporter BVDV replicons rNS3-5B and rp7-NS5B as indicated:
ternal ribosome entry site of EMCV. (B) Fireﬂy luciferase activity from total cell lysates
lled square), rp7-NS5B (open triangle) and rNS3-5Bgdd (diamond), respectively. All values
cistronic RNA co-electroporated with the replicon RNA transcripts. Data represents one of
of rNS3-5B (lane 2), rp7-NS5B (lane 3) in NCL1 cells at the indicated hours (hrs) after
). Panel ‘a’ shows replicon RNA in total cellular RNA extracted from 1×106 cells. Panel ‘b’ is
probed inpanel a. (D) Transduction of luciferase expression to naïve (indicator) cells using
re electroporationwith reporter BVDV replicon RNAs. Luciferase activities were tested 48 h
replicons refer to replicons recovered from source cells transfected with RNA transcripts
red from indicator cells following inoculation with packaged replicons.
333D. Liang et al. / Virology 387 (2009) 331–340More importantly, luciferase levels were found to correlate with the
intracellular amounts of replicon RNA as indicated by northern blot
hybridization (Fig. 1C). The luciferase levels from the BVDV replicons
were normalized for electroporation efﬁciency by quantiﬁcation of a
co-electroporated RNA encoding Renilla luciferase. To this end, a
fraction of the electroporated cells was cultured separately in which
Renilla luciferase activity was monitored at 4 h post-electroporation
(data not shown). An excellent correlation was observed between
normalized RNA levels as detected by northern blot analysis and
normalized ﬁreﬂy luciferase expression at all time points analyzed
(Figs. 1B, C). However, it appeared that the kinetics of RNA accumula-
tion was slightly different between the two reporter replicons, with
rNS3-5B RNA accumulation delayed relative to rp7-NS5B.
Previous studies have demonstrated that BVDV replicons can be
packaged by infecting with helper BVDV virus, like the naturally-
occurring pestivirus defective interfering (DI) particles that they
emulate (Behrens et al., 1998; Meyers and Thiel, 1995). To ascertain ifFig. 2. Packaging of BVDV replicons using recombinant vaccinia viruses expressing different l
virus genome expressing different lengths of BVDV proteins. The thymidine kinase (TK) gen
the C-terminal end of the BVDV genome: T7=T7 promoter, R=Ribozyme of hepatitis D viru
analysis of NCL1 cells infected with recombinant vaccinia virus expressing different length of
lane of an 8% SDS-PAGE gel, electrophoresed, transferred to a membrane and protein dete
represent NCL1 cells infected with recombinant vaccinia virus vT7-cpNgdd, vT7-ncpNgdd, vT
represents NCL1 cells persistently-infected with ncp-BVDV. (C) Trans-packaging of BVDV re
wild type (WR) or vT7-ncpNgdd vaccinia viruses after 36 h post-RNA electroporation of the
and applied onto naive cells. Luciferase activities were tested 48 h after electroporation or in
replicon rp7-NS5B. A fraction of the supernatant was incubated with 100 serum neutralizing
naive NCL1 cells. Data represents one of the repeated experiments. (D) Semliki Forest vir
electroporated with transcripts derived from SFV3-lacZ. Four hours post-RNA electroporation
β-galactosidase after 8 h (panel a). The supernatant from these cells was collected 24 h post-R
(indicator cells) and further analyzed for expression of β-galactosidase after 12 h (panel b)the introduction of foreign RNA elements into the BVDV subgenomic
RNA might interfere with its encapsidation, we electroporated the
reporter replicon RNAs into helper BVDV genotype 2 (BVDV-2)
infected cells and analyzed the cell culture medium harvested 2 days
after electroporation for its ability to transduce luciferase expression in
bovine cells. The results revealed that both versions of reporter
replicons were able to transduce luciferase expression in the indicator
cell monolayer (Fig. 1D) and there were no signiﬁcant differences
between the rNS3-5B and rp7-NS5B replicons in the release of virions
into the culture ﬂuids (Fig. 1D). The levels of luciferase expression in
the transduced cellswerehigher than in the electroporated cells. These
results indicated that replicons rNS3-5B and rp7-NS5B retain the
necessary cis-elements for packaging, although it is not known if BVDV
structural proteins can exclude foreign RNA molecules.
A recent report indicated that encapsidation of the BVDV genome
was strictly dependent on the presence of the NS2-3 protein (Agapov
et al., 2004). The ﬁnding that the two reporter replicons differing in theengths of BVDV proteins in trans. (A) Schematic representation of recombinant vaccinia
e of vaccinia virus WR was replaced with BVDV coding regions having truncations from
s. Asterisk (⁎) with NS5B indicates the mutation of GDD motif to ATR. (B) Western blot
BVDV proteins. Total cell lysate corresponding to 2×104 NCL1 cells was loaded into each
cted using monoclonal antibodies against E2 (panel a) or NS3 (panel b). Lanes 1 to 5
7-ncpNS2-3, vT7-p7 and vT7-E2, respectively. Lane 6 is normal control cells while lane 7
plicons using recombinant vaccinia virus vT7-ncpNgdd. NCL1 cells were infected with
two replicons. The trans-packaged replicon pseudo-particles from the cells were ﬁltered
fection of replicons. White bars represent replicon rNS3-5B, while gray bars represent
units of BVDV neutralizing antibody for 30 min at room temperature prior to infection of
us replicons fail to be packaged by vaccinia virus vT7-ncpNADLgdd. NCL1 cells were
, cells were infected with vaccinia virus vT7-ncpNADLgdd and stained for expression of
NA electroporation, passed through a 0.1 mm ﬁlter and applied to fresh NCL1 naive cells
.
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presence of helper ncp-BVDV infection prompted us to determine the
minimumcomplementof viral proteins required for the incorporation of
the subgenomic reporter replicon into virus particles. To this end, we
engineered a helper vaccinia virus expression system that could
generate either the entire wt BVDV genomic RNA and efﬁciently encode
theBVDVpolyprotein in infected cells or any selectedmutants of interest
(e.g. deletion mutants or mutants with BVDV polyprotein having a
catalytically inactive NS5B) (Fig. 2A). The engineered vaccinia viruses,
vT7-NADLand vT7-cpNgdd, expressed the entire polyprotein of BVDV in
infected cells (Fig. 2B) and nearly 100% of the cells were positive by
indirect immunoﬂuorescence staining using an anti-E2 monoclonal
antibody (Mab) (data not shown).Western blot analyses of vT7-cpNgdd
infected cells revealed expression and correct processing of E2 and NS3
(Fig. 2B). The vT7-NADL released infectious BVDV into the culture
medium (data not shown).
To assess the efﬁciency of the complete set of BVDV proteins
expressed by the vaccinia system in encapsidating BVDV reporter
replicons into functional viral particles, we analyzed the expression of
luciferase in indicator cells inoculated with cell culture medium from
the packaging cells, the rNS3-5B or rp7-NS5B RNA electroporated cells
following infection with the helper vT7-ncpNgdd recombinant
vaccinia virus. The culture ﬂuid from the packaging cells was passed
through a 0.1 μm ﬁlter to remove the vaccinia virus and the ﬁltered
ﬂuid inoculated onto a fresh monolayer of indicator cells to assess
transduction of luciferase expression. Luciferase activity measured
from the indicator cells revealed the delivery of the replicon rNS3-5B
and rp7-NS5B to the new monolayer (Fig. 2C). Delivery of the two
packaged replicons have comparable efﬁciency. In contrast, wild type
vaccinia virus WR could not trans-package the BVDV replicon, hence
only background levels of luciferase activity were detected (Fig 2C).Fig. 3. Requirement of different sets of BVDV NS proteins to package rp7-NS5B and rNS3-5B
being electroporated with replicons (A) rp7-NS5B or (B) rNS3-5B. The trans-packaged repl
cells. Luciferase activities were measured 48 h after electroporation or infection of repliconFurthermore the transduction of luciferase activity to the indicator
cellswas blocked bypre-incubation of the cell culture ﬂuidswith BVDV
neutralizing Mabs against E2 (Fig. 2C) indicating that the packaged
replicon contained authentic BVDV E2 protein on the surface. Taken
together, these results demonstrate that the replicon RNAs were
encapsidated and transduced luciferase expression in the target cells.
These encapsidated virions were also able to pass through a 0.1 μm
ﬁlter with which vaccinia virus virions were effectively excluded.
BVDV virion packaging machinery is highly selective
Although the packaging of the reporter replicon by trans-
complementing with recombinant BVDV-vaccinia appears to recapi-
tulate the natural process of DI propagation, the mechanism
responsible for packaging the RNA is still unknown. The efﬁciency of
virus assembly would be enhanced by the selectivity of the genome
packaging machinery. Such selectivity should be correlated with the
failure to encapsidate a non-cognate viral RNA genome that is present
in abundant quantities within the cytoplasm of the packaging cells.
To demonstrate the selectivity of Pestivirus genome encapsidation
we chose to exploit an alphavirus replicon system due to the
similarities between Togaviruses and Flaviviruses in terms of RNA
replication and assembly (Strauss and Strauss, 1994). We used a
Semliki Forest virus (SFV) alphavirus replicon (SFV3-lacZ, Invitrogen,
Carlsbad, CA) that accumulates to high levels in electroporated cells
(Liljestrom and Garoff, 1991). This replicon encodes the SFV NS
polyprotein from the genomic promoter, as well as the Escherichia coli
β-galactosidase (β-gal) reporter protein from a subgenomic promoter
(Liljestrom and Garoff, 1991). Preliminary studies showed that a SFV
replicon replicated efﬁciently in several bovine cells after electro-
poration (data not shown). The SFV3-lacZ RNA transcriptsreplicons. NCL1 cells were infected with different recombinant vaccinia virus 36 h after
icon pseudo-particles from RNA electroporated cells were ﬁltered and applied to naive
s.
335D. Liang et al. / Virology 387 (2009) 331–340electroporated into bovine cells and infected with helper vT7-
ncpNADLgdd or BVDV-2 directed the expression of high levels of β-
galactosidase in the packaging cells (Fig. 2D, panel a). However, no β-
galactosidase could be detected in the indicator cells inoculated with
the cell culture ﬁltrates from RNA electroporated cells (Fig. 2D, panel
b). These results indicated that the pestivirus packaging machinery
has a strong selection for the RNA genome, although the packaging
signals at the RNA level have not yet been deﬁned.
Segregation of BVDV polyprotein expression between NS3 and NS4A
leads to the failure of virion packaging
The results presented above validated the use of the recombinant
vaccinia helper system to encapsidate and transduce BVDV replicons.
Previous studies had indicated that NS2, NS3, NS4A and NS5B played a
role in the assembly of infectious virions (Agapov et al., 2004; Ansari
et al., 2004). To determine the minimum complement of viral proteins
required in trans to package the rp7-NS5B RNA (expressing all the NS
proteins) into infectious particles, we engineered a vaccinia virus
vT7-E2 which expresses the BVDV structural proteins, C, Erns, E1 and
E2, with the autoprotease, Npro, at the N-terminus of C to conserve the
normal biogenesis of its N-terminus (Fig. 2A). The Npro is neither a
component of virions, nor is it required for pestivirus virion assembly
(Lai et al., 1999). Preliminary studies showed that vaccinia recombi-
nants expressed and processed both E2 and NS2-3/NS3 as expected,
due to the presence of signal sequences and the Jiv90 element,
respectively (Lackner et al., 2006).Fig. 4. Characterization of recombinant vaccinia viruses expressing truncated ncp-BVDV p
Schematic representation of recombinant vaccinia virus genome expressing ncp-BVDV polypr
sizes of truncated BVDV polyprotein, respectively. T7=T7 promoter, R=Ribozyme of hep
vT7-NS4AM (retained middle domain but deleted C-terminal) and vT7-NS4AN (retained o
recombinant vaccinia viruses. Cell lysate corresponding to 2×104 NCL1 cells were loaded in e
a primary monoclonal antibody against NS3. Note NS4AN was not processed from NS2-3 inOur results indicate that vT7-E2 helper transduced replicon rp7-
NS5B (luciferase) to target cells (Fig. 3A). However, the efﬁciency of
this process was signiﬁcantly lower compared to that of the vT7-
ncpNADLgdd or vT7-cpNADLgdd helper packaged, suggesting that
some of the BVDV NS proteins contributed to efﬁcient virion assembly.
Therefore, we constructed and evaluated another vaccinia BVDV
recombinant that expressed the structural proteins and p7 (vT7-p7).
This helper vaccinia-BVDV recombinant yielded equivalent trans-
packaging efﬁciency as the complete polyprotein from vT7-
ncpNADLgdd or vT7-cpNADLgdd (Fig. 3A). These results indicated
that only the structural proteins are required in trans to package
cognate replicons expressing all the NS proteins. The efﬁciency of the
process is greatly enhanced by the addition of p7 to the polyprotein
that gives rise to the structural proteins, suggesting a possible
interaction between E2 and p7 (role for the precursor E2-p7) in
replicon packaging, and by extension, in the assembly of progeny
virions during BVDV infections.
In contrast with the rp7-NS5B replicon, the rNS3-5B failed to be
packaged by the structural proteins expressed under identical
conditions (Fig. 3B). Furthermore, rNS3-5B failed to be packaged by
helper expression of additional NS proteins, p7 and NS2-NS3 (Fig. 3B).
The functionality of the complementing vT7-ncpNS2-3 recombinant
vaccinia was demonstrated by packaging of the rp7-NS5B, suggesting
that failure to package is not due to undetected mutations within
structural genes. Furthermore, a different version of recombinant
vaccinia virus, vT7-cpNS3, expressing polyprotein Npro-NS3 derived
from cp-BVDV strain NADL, also failed to package rNS3-5B (data notolyproteins and its utilization for packaging of rNS3-5B and rp7-NS5B replicons. (A)
oteins. The thymidine kinase (TK) gene of vaccinia virusWRwas replacedwith different
atitis D virus. (B) NS4A amino acid sequences included in vaccinia virus vT7-NS4A,
nly N-terminal). (C) The expression and processing of NS3 in cells infected with these
ach lane of 8% SDS-PAGE and detection of NS3 was performed by western blotting using
the vT7-ncpNS4AN vaccinia construct.
Fig. 5. Mapping of minimum sets of nonstructural polyproteins required for trans-
packaging of rNS3-5B. NCL1 cells were infected with different recombinant vaccinia
viruses 36 h after being electroporated with replicon rNS3-5B or rp7-NS5B. The trans-
packaged replicon pseudo-particles from the packaging cells were ﬁltered and passed to
naive cells. Luciferase activities inpackaging cells and indicator cellsweremeasured 48h
after electroporation or infection of replicons. White bars represent replicon rNS3-5B,
while gray bars represent replicon rp7-NS5B. (A) Mapping of the nonstructural
polyproteins required for trans-packaging of rNS3-5B and rp7-NS5B replicon using
vT7-ncpNS4B, vT7-ncpNS5A and vT7-ncpNS5B in trans. (B) Mapping of the nonstruc-
tural polyproteins required for trans-packaging of rNS3-5B and rp7-NS5B replicon using
vT7-ncpNS2-3, vT7-ncpNS4AN, vT7-ncpNS4AM and vT7-ncpNS4A in trans.
Table 1
Summary of BVDV replicon trans-packaging results with different recombinant vaccinia












Replicon rp7-NS5B contains BVDV polyprotein from p7 to NS5B, while rNS3-5B contains
polyprotein from NS3 to NS5B. Recombinant vaccinia viruses express BVDV
polyproteins from Npro to E2, p7, NS3, NS4A N-terminus, NS4A middle domain, NS4B,
NS5A, NS5B, respectively. +: packageable; −: unpackageable.
336 D. Liang et al. / Virology 387 (2009) 331–340shown). Taken together, these results suggest that the polyprotein
downstream of NS3 is involved in efﬁcient packaging of rNS3-5B.
It was surprising that vT7-cpNS3 could not trans-complement
rNS3-5B for packaging. It is worth noting that the cells harboring the
rNS3-5B replicon, expressed precursor NS3-NS4A-NS4B-NS5A-NS5B
that could be processed into functionally mature proteins. Simi-
larly, recombinant vaccinia virus, vT7-cpNS3, expressed precursor
Npro-Erns-E1-E2-p7-NS2-3 that could be processed by host cellular
signal peptidase. The two precursors overlap in the NS3 region,
therefore, the cells harboring both rNS3-5B and vT7-cpNS3 expressed
two truncated polyproteins that covered the entire BVDV genome. We
demonstrated that efﬁcient trans-packaging of rNS3-5B could be
achieved by co-infection with recombinant vaccinia virus
vT7NADLgdd, which expresses the entire BVDV polyprotein with the
GDD motif in NS5B mutated to null the replication activity (Fig. 3B).
Thus, the failure of rNS3-5B to be packaged by vT7-cpNS3 indicated
that contiguous expression of nonstructural proteins NS2-3 with its
downstream polyproteins is essential for the efﬁcient incorporation of
rNS3-5B into functional virus particles.
Contiguous expression of NS2-3-4A is essential for efﬁcient
virion packaging
To identify the critical NS proteins responsible for the failure to
incorporate rNS3-5B genomes into virion particles, we analyzed their
packaging using a recombinant vaccinia virus that expressed the
structural proteinswith the NS protein segment, p7-NS4A or p7-NS5A,
as a single polyprotein derived from ncp-BVDV (Fig. 4A). Western
blotting showed that all the vaccinia recombinants expressed and
processed E2 and NS2-3 proteins correctly (Fig. 4C, lanes 4, 5, 6).
Recombinants vT7-NS4B, vT7-NS5A and vT7-NS4A packaged therNS3-5B replicon with equivalent efﬁciency to that of rp7-NS5B,
respectively (Figs. 5A, B). These results indicate that all of the proteins
upstream of, and including NS4A could be provided in trans for
efﬁcient virion packaging. However, we have demonstrated that rNS3-
5B could not be efﬁciently trans-packaged by recombinant vaccinia
virus expressing polyprotein Npro-NS3. The packaging efﬁciency of the
rNS3-5B replicon by complementation with vT7-NS4A was compar-
able with vT7-NS4B, vT7-NS5A and vT7-Ngdd (Figs. 5A, B). These
results suggest that the sequence context downstream of NS4A is not
essential for NS2-3-4A processing or complex formation. However, we
could not exclude the possibility of involvement of the polyprotein,
NS4B-5B region, in virion packaging (Ansari et al., 2004).
The C-tail of NS4A is indispensable for efﬁcient virion packaging
The most signiﬁcant role of NS4A is to function as a cofactor in the
NS3-mediated cleavage of the viral polyproteins (Tautz et al., 2000; Xu
et al., 1997). Because the central domain of NS4A is critical for this
function, we engineered a C-terminal deletion NS4A mutant,
vT7-NS4AM, and another mutant lacking both the C-terminal domain
and the middle domain of NS4A, vT7-NS4AN. The hydrophobic
N-terminus of NS4A is predicted to adopt a helix conformation,
which is likely to insert itself into membranes (Fig. 4B). Western
blotting results showed that NS2-3 was processed efﬁciently from its
NS4AMprecursor (Fig. 4C, lane 3). It is important to note that the NS2-
3-4AN precursor expressed from vT7-NS4AN was larger than the
normal NS2-3 molecule by ∼2.2 kDa, indicating that the N-terminal
domain of NS4Amolecule was retained with NS2-3 precursor (Fig. 4C,
lane 2). Both replicons, rNS3-5B and rp7-NS5B, were efﬁciently
packaged by the recombinant vaccinia virus, vT7-ncpNS4A (Fig. 5B).
However, none of the vaccinia virus recombinant NS4A deletion
mutants, vT7-NS4AN and vT7-NS4AM, were able to complement
packaging of the rNS3-5B replicon (Fig 5B). A summary of the
packaging of the two replicons with different recombinant vaccinia
virus mutants is given in Table 1. These ﬁndings suggest that the C-tail
of NS4A is indispensable for efﬁcient virion packaging.
The close link between BVDV virion packaging and replication machinery
Our results correlate with recent ﬁndings on the involvement of
several NS proteins in the packaging of genomes generated by an
active viral replicase complex (Agapov et al., 2004; Ansari et al., 2004).
Furthermore, Agapov et al., 2004 demonstrated the importance of the
NS2-3 precursor in the production of infectious virions, although NS2
was dispensable for genome replication (Agapov et al., 2004). Taken
together with the results presented above, the role of NS2 and NS2-3
precursors may involve the engagement of the replicase complex by
the structural proteins. To examine the recognition of the replication
machinery by the structural proteins, we analyzed the production and
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genome and the BVDV genome having an inactive NS5B. Cells were
infected with these recombinant vaccinia viruses and culture super-
natants collected at 16 h post-infection. Total cell lysates and culture
supernatants were analyzed by western blot analysis to assess the
levels of BVDV E2 protein expression in infected cells and supernatant
which will indicate the virion released into the media. Fractions that
co-sedimented with standard BVDV infectious virions (density 1.12 to
1.14) were found to contain detectable E2 (Fig. 6, lane 6) and to be
infectious to bovine cells (data not shown).
The relative amounts of E2 present in the culture supernatant of
cells infected with vaccinia virus recombinants expressing wt NS5B
or the catalytically inactive NS5Bgdd were determined by densito-
metry and normalized by the relative amounts of total E2 expressed
in the infected cells. Vaccinia-derived BVDV genomes with inactive
NS5B but otherwise normal polyprotein, released only 20% of
the virions compared to the cells infected with vT7-cpNADL (Fig 6,
lanes 5 and 6). Furthermore, the virion produced by vT7-cpNgdd
were noninfectious in bovine cells (data not shown). On the other
hand the amount of expressed E2 in vT7-Ngdd infected cells (lane 2)
was slightly greater than the vT7-cpNADL (lane 3). This difference
may be due to the fact that in vT7-cpNADL infected cells, part of the
E2 is used for authentic virion production, while in vT7-cpNgdd
infected cells most of the E2 is retained inside the cells. It was also
evident that viral genome replication in vT7-cpNADL infection did
not lead to increased production of E2 inside the cells (lane 3) as
compared to vT7-cpNgdd (lane 2) due to the production of high
levels of transcripts generated by vaccinia infection. Hence, the
expressed protein from viral replication is masked by expression
products derived from vaccinia transcripts. These results strongly
suggest that active genome replication enhances the production and/
or release of virions and are also consistent with the previous reportFig. 6. Lack of genome replication is correlated with reduced efﬁciency of virion
assembly and release. RK-13 cells were infectedwith both T7 helper vaccinia virus vTF7-
3 and vT7-cpNADL or vT7-cpNgdd, respectively. The supernatant which contains both
rVV and BVDV virions was ﬁltered through 0.1 mm ﬁlter and centrifuged to pellet the
virions. The infected cell lysates and virion pellets were resolved on 8% SDS-PAGE and
western blot analysis was performed using a monoclonal antibody against BVDV E2.
Lanes 1–3 represent cell lysates from the infected cells with vTF7-3, vTF7-3+vT7-
cpNgdd and vTF7-3+vT7-cpNADL, respectively, while lanes 4–6 indicate the super-
natant from their corresponding infected cells.where involvement of the NS5B in genome packaging is demon-
strated (Ansari et al., 2004).
Discussion
We have developed an efﬁcient BVDV reporter replicon packaging
system, in which both the minimum replicon, rNS3-5B, and the long
replicon, rp7-NS5B, replicated and assembled with comparable
efﬁciency. We employed a recombinant vaccinia virus system to
express the BVDV packaging proteins rather than a BVDV helper virus
or dual replicon approach (Agapov et al., 2004). The pure progeny
BVDV virions can be easily separated from recombinant vaccinia
virions by ﬁltration. The efﬁciency of the trans-packaging system
using recombinant vaccinia virus expressing polyprotein from Npro to
NS4A is comparable to that using a helper BVDV virus, which occurs in
nature. Furthermore, the introduction of recombinant vaccinia virus
during the late stages of BVDV replicon replication minimizes viral
recombination opportunity. Our unpublished data has shown that a
chimeric BVDV genome up to 15 kb in length could be efﬁciently
assembled into infectious virions. Therefore, the relatively large
cloning capacity of the replicons accommodates different purposes.
The desired heterologous genes could be effectively cloned into the
ﬁreﬂy luciferase or neomycin phosphotransferase gene position. Thus,
this replicon trans-packaging system can serve as a gene delivery
system at the cellular or animal level.
Consistent with our results, Agapov et al. (2004) reported that
uncleaved NS2-3 was required for the production of infectious BVDV.
Both, the system used by Agapov et al. (2004) and our system
demonstrated the importance of the expression of NS4A in cis with
NS2-3 protein. In contrast to our results, Agapov et al. (2004)
determined that the expression of NS4A in cis with NS2-3 was not
essential for, but markedly increased the packaging efﬁciency. This
difference may be due to the different packaging systems used in the
studies. Agapov et al. (2004) used a secondBVDV replicon to express the
functional NS2-3-4A in trans, while we used a recombinant vaccinia
virus to express the functional NS2-3-4A in trans. This may result in
different protein localization and different packaging efﬁciencies.
High levels of NS3 are expressed by cp-BVDV which is well
correlated with an enhanced accumulation of intracellular viral RNA
as compared to ncp-BVDV strains (Lackner et al., 2004).However, virion
production from cp-BVDV is not signiﬁcantly different than that from
ncp-BVDV in tissue culture. This indicated that a greater level of viral
genome and packaging proteins were not enough for increased virion
production. It has been demonstrated that NS2-3was involved in virion
assembly. However, it was surprising that expression of NS2-3-4A, but
not NS2-3, could complement replicon assembly in our packaging
system, suggesting that the NS2-3-4A precursor was involved in virion
assembly. We also observed that extending NS2-3-4A to NS2-3-4A-
NS4B or NS2-3-4A-NS4B-NS5A did not increase the packaging
efﬁciency of rNS3-5B. This demonstrated that the region downstream
of NS4A could be separated from NS2-3-4A for assembly function.
Thus, the contiguous expression of Npro-Erns-E1-E2-p7-NS2-3 with
NS4A contributes to the successful trans-packaging of rNS3-5B. A
previous report suggested that p7 could be separated from E2 and NS2
with efﬁcient virion packaging (Harada et al., 2000). Therefore, our
results indicate that the contiguous expression of NS2-3-4A is
essential for efﬁcient trans-packaging of rNS3-5B. Based on the
information that NS3 cannot be functionally replaced by uncleaved
NS2-3, as well as, the strict correlation between NS3 level and
efﬁciency of RNA replication (Lackner et al., 2004), this strongly
suggested that NS3, but not NS2-3, is an essential component of the
viral replication complex. Thus, we propose that precursor NS2-3-4A,
provided by the recombinant vaccinia viruses, was involved in
efﬁcient virion trans-packaging but not virus replication.
Having shown the importance of the NS2-3-4A precursor protein,
we suggest that cp-BVDV also employs this precursor for the virion
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for different viral functions. The temporal regulation of NS2-3-4A
autoprocessing is likely necessary for the switch between the phases
of highly active viral RNA replication and virus morphogenesis. The
processing speed, order and ratio of the polyprotein precursor may
regulate different stages of the BVDV life cycle, i.e. translation,
replication and assembly. Although we did not provide evidence for
a direct role of the NS proteins in the recruitment of actively
replicating genomic RNA to assembly sites, the involvement of the
NS proteins in virion assembly provides an obvious candidate.
Materials and methods
Viruses, cells and reagents
Rabbit kidney (RK13, CCL-37), monkey kidney (CV1, CCL-70),
and thymidine kinase-deﬁcient human osteosarcoma (TK-143B,
CRL-8303) cells were obtained from the American Type Culture
Collection (Manassas, VA). Bovine uterine cells (NCL1) and mono-
clonal antibodies against BVDV proteins were gifts from Dr. Edward
Dubovi (Cornell University, Ithaca, NY). BVDV genotype 1 (BVDV-1)
isolate NADL (cytopathogenic) and vaccinia virus strain WR were
obtained from the AmericanType Culture Collection. BVDV genotype 2
(BVDV-2) isolate 890 was a gift from Dr. Julia Ridpath (USDA, Ames,
IA). Recombinant vaccinia virus producing the T7 RNA polymerase
(vTF7-3) was a gift from Dr. Bernard Moss (NIH, Bethesda, MD). DNA
restriction/modiﬁcation enzymes and luciferase assay systems were
purchased from Promega (Madison, WI). Fetal bovine serum (FBS),
γ-irradiated FBS (γ-FBS), equine serum, antibiotics for tissue culture
(penicillin and streptomycin premix), minimum essential medium
(MEM), Dulbecco's MEM (DMEM) and oligonucleotides were pur-
chased from Invitrogen (Carlsbad, CA). The NCL1 cells were grown in
MEM supplemented with penicillin–streptomycin and 10% equine
serum, while CV1 and TK-143B cells were grown in DMEM
supplemented with penicillin and 10% FBS. All cells were maintained
at 37 °C with 5% CO2. Plasmids encoding the full-length BVDV NADL
genome and its derivatives lacking the Jiv cellular insert that mediates
cytopathogenicity (Rinck et al., 2001) were described previously
(Vassilev et al., 1997). A plasmid that allows transcription of RNA
molecules encoding Renilla luciferase with expression driven by the
encephalomyocarditis virus (EMCV) IRES was described previously
(Ansari et al., 2004).
Construction of bicistronic subgenomic BVDV reporter replicons
Bicistronic reporter replicons, rNS3-5B and rNS3-5Bgdd, were
derived from the pNADLp15 full-length infectious genome of the
BVDV strain NADL described previously (Ansari et al., 2004; Vassilev
et al., 1997). Compared to rNS3-5B, rNS3-5Bgdd has a disabled NS5B
by virtue of replacing the conserved GDD motif (amino acid residues
447 to 449, using NS5B numbering) with ATR (Ansari et al., 2004).
Another replicon, rp7-NS5B, was constructed as described for rNS3-
5B, with the EMCV IRES inserted upstream of p7 rather than NS3. The
junction between Npro and p7 consisted of a stretch of nucleotides
encoding for short amino acid segments of the N- and C-termini of
capsid (C) protein, to mediate the correct membrane targeting of p7
and its subsequent processing. To this end, the central domain of the
capsid (nucleotides 909–1079, encoding amino acids 175–232 of the
wt virus polyprotein) (Genbank accession AJ133738) was deleted by
overlap extension PCR.
Construction of recombinant vaccinia viruses expressing BVDV
viral proteins
Construction of recombinant vaccinia viruses by homologous
recombination between a transfer plasmid carrying BVDV sequencesand the vaccinia virus WR genome was performed as previously
described (Ausubel et al., 1989). The cloning sites in the vaccinia
transfer plasmid were ﬂanked by the vaccinia virus DNA sequences,
TKL (left) and TKR (right). Different sizes of the BVDV truncated
polyproteins were ﬁrst cloned into the vaccinia transfer vector, pSC59
(Ausubel et al., 1989). The transfer vectors were engineered to contain
a T7 promoter with a transcription start site at nucleotide 1 of the
BVDV genome that contained either full-length BVDV genome cDNA
or deletions in the 3′ end of the open reading frame to generate C-
terminal truncated BVDV polyproteins. All constructs contained an
intact BVDV 3′ UTR immediately followed by the hepatitis D virus
ribozyme to yield a genuine BVDV 3′ end.
Vaccinia recombinants were generated in CV1 cells by transfecting
with the transfer plasmid DNA followed by infection with vaccinia
virus WR. Selection of recombinant vaccinia viruses lacking functional
TK was performed by passage in TK−143B cells in the presence of
5-bromodeoxyuridine (BrdU). Candidate recombinant viruses were
co-infected with vTF7-3 helper virus followed by the detection of
BVDV E2 protein expression in infected CV1 cells using indirect
immunoﬂuorescence microscopy and a speciﬁc mouse monoclonal
antibody against E2. The plaques expressing BVDV E2 were puriﬁed
three times and the expression and proper processing of all the
structural and NS proteins was conﬁrmed by western blotting. The
resulting recombinant vaccinia viruses (rVV) were termed vT7-
cpNADL, which expresses the full-length BVDV genomic RNA (from
the cpNADL strain) and vT7-cpNgdd, which expresses the full-length
BVDV genomic RNA of cpNADLwith the GDDmotif of NS5Bmutated to
ATR. Analogous vaccinia virus recombinants, termed vT7-ncpNADL
and vT7-ncpNgdd encode BVDV genomes that differ from the previous
ones in their NS2 protein lacking the insert of bovine origin. Additional
rVV were generated to express truncated versions of the BVDV
polyprotein namely: vT7-E2, vT7-p7, vT7-ncpNS2-3, vT7-ncpNS4AN,
vT7-ncpNS4AM, vT7-ncpNS4A, vT7-ncpNS4B, and vT7-ncpNS5A.
These viruses express the ncp-BVDV NADL strain polyprotein span-
ning fromNpro to E2, p7, NS3, NS4A N-terminus, NS4Amiddle domain,
NS4A, NS4B and NS5A, respectively.
In vitro RNA transcription and electroporation
DNA templates for in vitro transcription were produced by PCR
ampliﬁcation of the region containing the T7 promoter and the entire
replicon of the relevant plasmids using Klentaq polymerase (Clontech
BD Biosciences, Palo Alto, CA). In vitro RNA transcription was
performed using the T7-MEGAscript kit (Ambion, Austin, TX) as
described previously (Ansari et al., 2004). The pIRES-Renilla plasmid
was linearized with XbaI enzyme and used for RNA transcription as
described previously (Ansari et al., 2004). At all times the electro-
poration efﬁciency of the replicon RNA was monitored by co-
electroporation of a reporter RNA encoding Renilla luciferase in
which the expression was driven by the EMCV IRES. Corrections for
electroporation efﬁciency were not necessary due to the repeatedly
consistent levels of Renilla luciferase expression (105 RLU) in each
experiment.
RNA transcripts from a Semliki Forest Virus replicon, encoding β-
galactosidase (pSFV3-LacZ) (Invitrogen, Carlsbad, CA), were prepared
using plasmid DNA linearized with SpeI. Capped RNA transcripts were
synthesized in vitro with SP6-polymerase in the presence of m7G(5′)
ppp(5′)G cap analog by using the mMessage mMachine kit (Ambion,
Austin, TX). RNA concentration following transcription reactions was
determined ﬂuorometrically using Ribo-green (Molecular Probes,
Eugene, OR). An aliquot of the transcription reaction was analyzed by
formaldehyde agarose gel electrophoresis to determine the integrity
of the transcripts. Transcription reactions were stored at −80 °C in
small aliquots for electroporation purposes.
NCL1 cells (70 to 80% conﬂuent) were trypsinized, washed two
times with ice-cold DMEM and resuspended at a concentration of
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2004). Brieﬂy, transcripts (2 μg) were electroporated into 2×106 NCL1
cells in a 100 μl volume using a 0.2 cm gap cuvette with a single
electrical pulse discharge of 235 V, 100 μF and 48 Ohms. Replication of
the electroporated RNA was quantiﬁed by northern blot analysis of
cells harvested at various times post-electroporation as described
previously (Ansari et al., 2004). Electroporation experiments were
repeated aminimumof three times, starting from independent in vitro
RNA synthesis reactions.
Reporter assays
Fireﬂy and Renilla Luciferase assays were performed using the Dual
Luciferase Assay system (Promega, Madison, WI) following the
manufacturer's protocol. Brieﬂy, the NCL1 cells were harvested and
lysed in lysis buffer. An equivalent of 1×105 cells was used for the
measurement of luciferase enzyme activity. Light emission was
measured using a TopCount Luminescence Counter (Packard Instru-
ments, Meriden, CT). To detect expression of β-galactosidase in
transfected cells, monolayers were ﬁxed with 0.2% paraformaldehyde
in PBS for 5 min at room temperature. After 3 washes in PBS, the cells
were incubated in a chromogenic substrate solution containing
1 mg/ml X-gal (5-bromo-4-chloro-3-indolyl-13-D-galactopyrano-
side), 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide
and 2 mM MgCl2 in PBS. The appearance of blue color in the cell
monolayers was monitored following incubation at 37 °C. Images
were captured using wide-ﬁeld digital photomicroscopy at 6-hour
intervals for a period of 24 h.
Infections with recombinant vaccinia viruses, BVDV or
packaged replicons
Bovine cell monolayers were rinsed with PBS and inoculated with
cell culture ﬂuids containing vaccinia recombinants, BVDV or packaged
replicon virions in a volume sufﬁcient to cover the entire cell monolayer.
After adsorption for 1 h at 37 °C the supernatant was removed,
monolayer rinsed and supplemented with prewarmed complete media
and incubated in a 37 °C incubator until further analysis.
Western blotting
NCL1 cells (∼80% conﬂuency) were infected with each recombinant
vacciniavirus (multiplicityof infection,MOI=5) togetherwithT7helper
vacciniavirus (MOI=3) to achieve a greater level of expression. Total cell
lysateswere collected 12h after vaccinia infectionwhile ncp-BVDVor cp-
BVDV-infected cellswere harvested at 24 hpost-infection. Cell lysate, the
equivalent of ∼2×104 cells, was loaded into each well of an 8% SDS-
PAGE gel. Proteins were separated and electrotransferred to nitrocellu-
lose membranes (Hybond-C, Amersham, Arlington Heights, IL). Proteins
were detected usingmonoclonal antibodies against E2 (Antibody #4b6)
or NS3. Antibody binding was detected using a chemiluminescent assay
as described before (Ansari et al., 2004).
Trans-packaging of BVDV replicons following infection with either
recombinant vaccinia viruses expressing BVDV proteins or
with BVDV-2
Approximately 2 μg of replicon RNA transcript and 0.4 μg of Renilla
reporter RNA were mixed and electroporated into 2×106 NCL1 cells.
Aliquots of the transfected cells, termed the packaging cells, were
evenly distributed into ten fractions and plated in a 12-well-plate. One
well was harvested for luciferase activity at 48 h post-electroporation
to quantify the levels of packageable replicon RNA in the electro-
porated cells. The remaining nine wells were used for infection with
recombinant vaccinia viruses expressing BVDV proteins or with BVDV-
2 at 36 h post-electroporation. A system that employs a dual vacciniaT7 promoter–T7 RNA polymerase co-infection was used to express
BVDV RNA (Fuerst et al., 1987). To this end, cells previously
electroporated with replicon RNAwere co-infected with the recombi-
nant vaccinia viruses expressing BVDV under T7 promoter control
(MOI=5) and vTF7-3 recombinant vaccinia virus constitutively ex-
pressing T7 RNA polymerase (MOI=1). The cells were incubated for
an additional 24 h after which the medium containing packaged
replicons was harvested, passed through a 0.1 μm ﬁlter, reducing the
helper vaccinia virus titer to undetectable levels and stored at 4 °C for
further use. To assess the presence of packaged replicons, the culture
ﬁltrates (0.5 ml) were used to inoculate fresh NCL1 cells in duplicate
(termed indicator cells) in 12-well plates. The indicator cells were
cultured for 48 h and harvested to measure luciferase activity as a
reporter of the number of packaged replicons delivered to the
indicator cells by functional virions.
Virion release from cells infected with recombinant vaccinia virus
expressing wt or replication-incompetent BVDV genome
The RK-13 rabbit kidney cells (∼5×105) were co-infected with
vTF7-3 (MOI=3) and vT7-cpNADL or vT7-cpNgdd (MOI=5), for 1 h
at 37 °C. The infected cells were rinsed with PBS and cultured in
DMEM containing 2.5% γ-irradiated FBS for an additional 22 h. To
investigate the presence of released BVDV virions, culture ﬂuids were
collected and centrifuged at 13,000 g for 15 min at 4 °C to remove cell
debris and the supernatant ﬁltered through a 0.1 mm ﬁlter to remove
the vaccinia virions. The ﬁltrate was then centrifuged using a 10%
sucrose cushion and the fraction containing BVDV virions (density of
1.12 to 1.14) was collected and analyzed by western blotting as
described above. The infected cell monolayer was harvested in SDS-
PAGE sample buffer for subsequent analysis by western blotting to
determine the relative structural protein expression levels in the
different samples.
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